Deep TMS of Neural Circuits Associated With Stimulant Use Disorder

Description

This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with a methamphetamine use disorder (MUD).

Conditions

Methamphetamine Use Disorder, Transcranial Magnetic Stimulation

Study Overview

Study Details

Study overview

This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with a methamphetamine use disorder (MUD).

Deep TMS Neuromodulation of Neural Circuits Associated With Stimulant Use Disorder

Deep TMS of Neural Circuits Associated With Stimulant Use Disorder

Condition
Methamphetamine Use Disorder
Intervention / Treatment

-

Contacts and Locations

Palo Alto

VA Palo Alto Health Care System, Palo Alto, California, United States, 94304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, ferromagnetic metal in the head and body, claustrophobia, pregnant or breastfeeding or other ferromagnetic device/object in the head and body within 30 cm of the treatment coil.
  • * General medical condition, disease, or neurological disorder that interferes with the assessments or participation.
  • * Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk.
  • * Current substance abuse as determined by positive toxicology screen
  • * Have a mass lesion, cerebral infarct, or other active CNS disease, including a seizure disorder.
  • * A recent suicide attempt (defined as within the last 30 days) or presence of current suicidal plan or intent. Patients at risk for suicide will be required to establish a written safety plan involving their primary therapist before entering the study.
  • * Severe impediment to vision, hearing and/or hand movement, as this is likely to interfere with the ability to follow study protocols.
  • * Greater than mild traumatic brain injury (defined as greater than 10 minutes loss of consciousness).
  • * Taking benzodiazepines or neuroleptic medications, or any medication known to alter seizure threshold.
  • * Acute or unstable chronic illness.
  • * Current or lifetime history of bipolar disorder or psychosis.
  • * Participation in another concurrent intervention-based clinical trial.

Ages Eligible for Study

25 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Claudia B Padula, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Michelle R Madore, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2026-12-31